| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 14,034 | 9,490 | 3,537 | 13,495 | | Cost of Revenue | 8,660 | 5,453 | 3,833 | 9,102 | | | Gross Profit | 5,374 | 4,037 | (295) | 4,394 | | | Operating Expenses | | Research Development | 17 | 186 | 248 | 171 | | Selling General and Administrative | 3,760 | 3,569 | 3,346 | 3,655 | | Non Recurring | 63 |
-
|
-
|
-
| | Others | 278 | 241 | 294 | 266 | | | | Total Operating Expenses | 4,118 |
-
|
-
|
-
| | | | Operating Income or Loss | 1,255 | 40 | (4,183) | 302 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,726) | (672) | 2,007 | (130) | | Earnings Before Interest And Taxes | (1,470) | (632) | (2,176) | 172 | | Interest Expense | 302 | 290 | 284 | 273 | | Income Before Tax | (1,772) | (922) | (2,459) | (101) | | Income Tax Expense | 500 |
-
| (996) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,272) | (922) | (1,463) | (101) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (2,147) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,272) | (922) | (3,610) | (101) | | Preferred Stock And Other Adjustments | (374) | (375) | (282) | (399) | | | Net Income Applicable To Common Shares | ($2,647) | ($1,297) | ($3,892) | ($500) |
|
0.51% Nasdaq 
Income Statement
